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For several years now, disseminated cutaneous herpes simplex (1), formerly called
Kaposi's varicelliform eruption, has been known to be caused by the herpes simplex virus
as shown by Wenner (2) in 1944 and subsequently confirmed by other investigators. Pre-
viously Wise and Sulzberger (3) had suggested the herpes simplex virus as the cause of this
type of eruption.
Availability of aureomycin, an agent found effective against certain viruses, suggested
its use for therapy and prophylaxis of disseminated cutaneous herpes simplex. Braley
and Sanders (4) found this antibiotic to be effective in dendritic keratitis i.e. in herpes
simplex of the cornea. Their patients received hourly ocular instillations of an 0.5 per cent
solution of a borate salt having a pH of 7.5 to 7.8 when dissolved in isotonic sodium chloride
solution. The results of its use on herpes simplex infections of the cornea were striking.
Some of the patients received aureomycin parenterally in addition to the ocular
instillations. Fisher and Schwartz (5) found aureomycin to be effective in stomatitis
ulceromembranosa acuta.
The following are abstracts of two cases in which the combined systemic and topical use
of aureomycin appeared to have a striking effect.
CASE REPORTS
Case 1. C. J., a 24 year old, white, married woman had suffered from a severe atopic
dermatitis since infancy. She had a history of a disseminated cutaneous herpes simplex in
November 1940. When she came under our care in November 1948, she presented a severe
generalized eruption with a clinical picture characteristic of disseminated cutaneous herpes
simplex. This eruption had been preceded by small groups of blisters on the chin. She
now presented umbilicated vesicles and pustules, exudation, enlarged and tender lymph
nodes, edema, erythema, crusting and swelling, confined mainly to the face, neck, nipples,
upper chest and upper extremities, i.e. to those areas which were previously involved by the
atopic dermatitis. The temperature was 101.2°F. The blood count showed 8300 W.B.C.
i.e. a relative leucopenia.
The cutaneous eruption had almost completely subsided about 13 days after its inception
d after a stormy and febrile course. On the eighth hospital day, several corneal ulcers
were discovered and a diagnosis of bilateral herpetic (dendritic) keratitis was made by Dr.
I. Givner. At this time the vesicles and pustules on the skin areas had disappeared. After
a 24 hour trial with local application of ether, potassium iodide and homatropine, without
response, the patient was given hourly ocular instillations of a % solution of aureomycin.
In only 2 days the condition of the eyes was much improved.
Except for minor fluctuations of the atopic dermatitis, the patient's convalescence was
uneventful for a period of two months. At the end of this period she rather suddenly
developed three groups of herpetic lesions on the sides of the chin. Several of the sub-
mandibular lymph nodes again became swollen and tender. To avoid a recurrence of the
dissemination of the herpes simplex virus, aureomycin (250 mgs. orally 4 times daily) was
prescribed combined with 2% aureomycin in Qualatum (Almay), which was applied
* From the New York Skin and Cancer Unit, Department of Dermatology and Syphil-
ology (Dr. Marion B. Sulzberger, Chairman) Post-Graduate Medical School, New York
University-Bellevue Medical Center.
Received for publication February 10, 1949.
5
6 THE JOURNAL OF INVESTIGATIVE DERMATOLOGY
locally to the lesions and the surrounding areas of normal skin 3 to 4 times daily. Within
24 hours the lesions had commenced to dry up, and healing continued through the following
days. There had been no extension of the herpes simplex infection to other areas.
Case L J. N., a 38 year old, white male, had suffered from atopic dermatitis for many
years, in combination with asthma and hayfever. Three days prior to his visit to our
office, this patient developed some small "blisters" on the upper lip and, in the evening,
noticed extension to the mouth and neck. Intramuscular injections of penicillin and local
applications of bacitracin ointment, administered before his visit to our office, had failed
to control the spread of the eruption. On examination, this patient presented on the
bearded area of the neck, an extensive grouped eruption of typical herpetic vesicles on an
erythematous base, extending from one ear to the other. The right ear, the lower part of
the face and the perioral and glabellar areas were involved by a similar characteristic
herpetic eruption. On the ri.t side of the upper lip, the residue of the original "fever
blisters" was noted as a small indefinite patch of erythema and crusting. On the left side
of the palate there was a group of pinhead-sized eroded lesions. A diagnosis of disseminated
cutaneous and mucosal herpes simplex was made. Within 24 hours of aureomycin therapy
orally, (500 mgs. 4 times daily) and the local application of aureomycin 2% in (Qualatum)
(Almay), applied 3 times daily, there was dramatic improvement. The lesions com-
menced to dry up quickly and there was no sign of any further dissemination. The
attack was accompanied by regional lymph node enlargement but not by fever. Aureo-
mycin was continued by mouth and by local application for 1 week in order to forestall re-
currence of the eruption.
Comment: Disseminated cutaneous herpes simplex (Kaposi's varicelliform eruption)
is potentially a severe (and in exceptional instances fatal) disease for which no spe-
cific treatment has existed. Sulfonamides (6); pooled serum or plasma (7); penicillin and
immune globulin (8) have all failed to influence greatly the course of the disease. Results
of treatment with penicillin and moccasin venom in 1 case and with moccasin venom and
benadryl hydrochloride in the second case (9) were equivocal.
The above cited cases strongly suggest that the combined topical and systemic use of
aureomycin is effective in preventing the dissemination of localized herpes simplex (Cases
1 and 2) and in curing disseminated cutaneous herpes simplex (Case 2).
Much further laboratory and clinical work is necessary to establish the validity of the
efficacy of aureomycin in the treatment and prevention of disseminated cutaneous herpes
simplex. However, in view of the severity and potential danger of this not altogether un-
common disease, it appeared to us worthwhile to acquaint the medical profession with the
possible valuable effects of this new antibiotic.
SUMMARY
Experience in 2 cases of herpes simplex virus infection suggests, although it does not
prove, that combined systemic and local aureomycin therapy may be effective in preventing
cutaneous dissemination of herpes simplex virus, in patients with a tendency to such spread
e.g. patients with atopic dermatitis. It also suggests that, where the cutaneous dissemina-
tion has already occurred (disseminated cutaneous herpes simplex; formerly called Kaposi's
varicelliform eruption) aureomycin is a specific agent preventing further spread and quickly
healing lesions which are already present. The present study does not permit conclusions
as to whether the topical or systemic administration was the more effective, or whether the
combination was necessary or whether either alone would have sufficed to bring about the
improvements noted.
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